MedTrace Logo

Comparison Between Ultra-low-dose Computed Tomography and Lung MRI in Cystic Fibrosis

NCT04644471 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 185

Last updated 2026-02-13

No results posted yet for this study

Summary

The purpose of this study is to compare the performances of ultra-low dose computed tomography (CT) and lung magnetic resonance imaging (MRI) for morphological assessment of cystic fibrosis-related lung disease and to compare their performances to conventional low dose CT

Conditions

Interventions

DIAGNOSTIC_TEST

CT scanner

1 conventional low dose inspiratory acquisition and 1 ultra-low-dose inspiratory acquisition

DIAGNOSTIC_TEST

Lung MRI

3 UTE sequences (free breathing, inspiratory and expiratory) and 1 T2 sequence

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Marie-Pierre REVEL, MD, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-05
Primary Completion
2024-07-25
Completion
2024-07-25

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04644471 on ClinicalTrials.gov